Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 189.93

+0.5%

Jan 2 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cheryl Galt who wrote (3726)	6/25/1997 9:33:00 AM
From: N	of 32384

Update on S. 830 from Biocentury biocentury.com To follow on your post about FDA reform and PDUFA: The full Senate will vote on S. 830 ....after July 4 recess ...first modernization of drug and biologic regulation in three decades... not included Kennedy's amendment for compliance to conduct Phase IV trials as part of an accelerated approval... included Dodd's amendment for creation of a clinical trials database Kennedy proposal to require FDA designate officials responsible for facilitating rapid review of supplemental applications... Biocentury offers a month free trial subscription. Nancy Hammond

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next